Combined Immunotherapy, thoracic radiotherapy carries moderate toxicity in lung cancer

A study of the combination of radiation therapy and immune checkpoint inhibitors for the treatment of advanced lung cancer found a modest risk of side effects. The risk of pneumonitis appeared highest when thoracic radiotherapy was delivered after immune checkpoint inhibitor therapy.
Cancer Network